Roche received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the cobas® pure integrated solutions, the next generation of innovation in the cobas family of Serum Work Area solutions.
Florida, providing a clinical overview of dermatomyositis (DM) and the latest information on treatment options for the rare immune-mediated inflammatory disease.
A new phase II clinical trial validated the efficacy of Lunit's AI biomarker, Lunit SCOPE IO, in predicting outcomes of immunotherapy in patients with nasopharyngeal carcinoma.
If you want to track a person's activities for a day, you could call them up every ten minutes and ask what they're doing. Easier, though, would be to provide them with a journal to log their own actions.
Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, is pleased to introduce the AseptiQuik® STC connectors to its line of Steam-Thru® connectors.
Cold Spring Harbor Laboratory (CSHL) is at the forefront of using organoid technology to study and treat cancer. Organoids are tiny 3D clusters of cells that are miniature versions of patients' tumors.
"There is an increasing demand for HPAPIs due to their effectiveness against cancer at lower doses and the trend towards more targeted therapeutics.
Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, is pleased to introduce the MicroCNX™ Series to its line of genderless aseptic connectors.
Bruker Corporation (Nasdaq: BRKR) extends the power of mass spectrometry inside and outside the laboratory to Point-of-Need (PoN) analysis with the introduction of the DART-EVOQ® triple quadrupole mass spectrometer for high-throughput quantitative analyses.
Immunicom, Inc., a privately held clinical-stage biotechnology company with a transformative immuno-oncology platform, presented data from its ongoing clinical investigation [NCT04004910] at the Annual Meeting.